Maternal exposure to metformin and combination treatment of metformin and insulin was not associated with long-term increased risk of obesity, hypoglycemia, hyperglycemia, diabetes, or challenges in MSD compared with insulin. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.